This brand name is authorized in Nigeria.
The drug LUARTEM contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
C7D6T3H22J - ARTEMETHER
|
Artemether is an antimalarial agent used to treat acute uncomplicated malaria. It is administered in combination with lumefantrine for improved efficacy. This combination therapy exerts its effects against the erythrocytic stages of Plasmodium spp. and may be used to treat infections caused by P. falciparum and unidentified Plasmodium species, including infections acquired in chloroquine-resistant areas. |
|
2
|
UNII
F38R0JR742 - LUMEFANTRINE
|
This drug has been approved in Nigeria as follows:
Identifier | Form | Presentation | Description | Approval |
---|---|---|---|---|
C4-1967 | Tablet | Luartem Tablet 20/120mg TAB 20 mg; 120 mg 1 X 24 | Luartem Tablet 20/120mg C4-1967 Luartem ARTEMETHER+ LUMEFANTRINE ANTIMALARIA ARTEMETHER 20MG, LUMEFANTRINE 120MG TABLETS 1 X 24 OVER THE COUNTER TREATMENT OF UNCOMPLICATED MALARIA ONIFAM LABORATORIES LTD. NIGERIA FLUORISH PHARMA. INDIA 01/27/2022 01/26/2027 | 27/01/2022 |
C4-1968 | Tablet | Luartem Tablet 80/480mg TAB 80 mg; 480 mg 1 X 6 | Luartem Tablet 80/480mg C4-1968 Luartem ARTEMETHER + LUMEFANTRINE ANTIMALARIA ARTEMETHER 80MG, LUMEFANTRINE 840MG TABLETS 1 X 6 OVER THE COUNTER TREATMENT OF UNCOMPLICATED MALARIA ONIFAM LABORATORIES LTD. NIGERIA FLUORISH PHARMA. INDIA 01/27/2022 01/26/2027 | 27/01/2022 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC Group | Classification | |
---|---|---|
P01BF01 | Artemether and lumefantrine | P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01B Antimalarials → P01BF Artemisinin and derivatives, combinations |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
NG | Registered Drug Product Database | C4-1967, C4-1968 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.